Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167726 · ClinicalTrials.gov registry record
Neuraxial and Neurolytic Analgesia for Intractable Pain
A clinical trial of Pain, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 19
- Enrollment target
- 1
- Study location
NCT00167726 is a study of Pain that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 19 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00167726, a study of Pain, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect longitudinal data on outcomes of neuraxial or neurolytic procedures in patients with intractable cancer and chronic noncancer pain so that we may contribute to the growing evidence for or against these therapies and to provide data for ongoing quality improvement activities.
Conditions Studied
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2005-01 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167726
The ClinicalTrials.gov registry entry for NCT00167726 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (94% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 0 interventions.
NCT00167726 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00167726 about?
NCT00167726 is a clinical study titled "Neuraxial and Neurolytic Analgesia for Intractable Pain". The purpose of this study is to collect longitudinal data on outcomes of neuraxial or neurolytic procedures in patients with intractable cancer and chronic noncancer pain so that we may contribute to the growing evidence for or against these therapies and to provide data for ongoing quality improvem...
What is the current status of trial NCT00167726?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2005-01. Estimated completion is 2011-06.
What conditions does trial NCT00167726 study?
This clinical trial studies the following conditions: Pain.
Who is sponsoring clinical trial NCT00167726?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00167726 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.